Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of the AIDA STEMI (Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction) cardiac magnetic resonance (CMR) substudy was to investigate potential benefits of intracoronary versus intravenous abciximab bolus administration on infarct size and reperfusion injury in ST-segment elevation myocardial infarction.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Am Coll Cardiol

Title: Journal of the American College of Cardiology

Publisher: Elsevier BV

ISSN (Electronic): 1558-3597

ISSN (Print): 0735-1097

Publication date (Electronic): Apr 02 2013

Volume: 61

Issue: 13

Affiliations

[1 ] Heart Center, Department of Internal Medicine, Cardiology, University of Leipzig, Leipzig, Germany. ingoeitel@gmx.de

Article

Publisher Item ID: S0735-1097(13)00588-3

DOI: 10.1016/j.jacc.2013.01.048

PubMed ID: 23466078

SO-VID: 9e7877ed-f46c-4afc-8e41-fa253c58a1c1

History

Data availability:

Comments

Comment on this article

scite_

Cited by 59

See all cited by

- Version 1